# EVERSPACE™

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

- Steam appid: 396750
- Developer: ROCKFISH Games
- Released: 2017 · Genre: Action · List price: $19.99
- Deal grade: B (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $2.3k to $3.5k per month (mid $2.9k)
- Opportunity score: $4.4k/month at x1.50 dormancy multiplier
- Est. lifetime owners: 538.4k · Est. lifetime net revenue: $2.3M
- Review sentiment: 78% positive across 11458 reviews (9789 from Steam purchases)
- Review velocity: 27.2 reviews/month (6-month average)

## Why it's flagged

- Developer active, last post 8 months ago
- Studio active elsewhere (2 titles tracked), so this one may welcome a partner
- Last build shipped 7.0 years ago
- Last discounted 1 months ago, 11 sales in the last 12 months

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $5.3k |
| After VAT / sales tax (-13% blended) | $4.6k |
| After refunds (-9.5% median) | $4.2k |
| Net to developer (after Steam 30%) | $2.9k |

## Monthly review counts, oldest to newest (24 months)

18, 27, 28, 35, 65, 42, 32, 34, 32, 80, 30, 51, 35, 43, 33, 24, 39, 34, 39, 31, 30, 30, 15, 18

## Estimated acquisition range

$70.0k to $140.1k (2-4x the trailing net annuity of $35.0k/year). Same error range applies.

## Analyst notes (AI-assisted)

Everspace is a roguelike space shooter with third-person arcade combat, procedural runs, and progression-based unlocks released in 2017.

A quiet performer earning $2.9k/mo in residual revenue with a 78% positive ratio and stable 27 reviews/mo, Everspace occupies a narrow but durable niche in space-action roguelikes. The title has shipped a successful sequel (2023) and maintains light developer engagement; acquisition of the first game alone offers limited upside, but republishing or bundling with Everspace 2 could extend monetization in emerging markets or subscription services. The low velocity (11 sales in last 12m) and high elasticity (1.19) suggest price sensitivity and audience fatigue on PC, not lack of interest in the franchise.

- Most realistic play: publishing
- Risk (market): Everspace 2 (2023) is mechanically and commercially superior, likely cannibalizing sales of the original; bundling or delisting the first title may be necessary to avoid overlap.
- Risk (tech): Player reports mention cutscene crashes and balance issues (Heavy class lacking shields); technical debt may require investment to sustain positive sentiment.
- Risk (other): Roguelike genre audience is saturated; Dead Cells, Hades, and similar titles dominate discovery and spending on Steam.

What players are asking for:
- More ship variety and loadout options
- Improved UI clarity (weapon/shield energy indicator placement criticized)
- Better pacing and story exposition early in runs
- Ship class balancing, especially defensive ships

Suggested first moves:
1. Audit technical debt: prioritize cutscene crash fixes and class balance patches to stabilize the 27 reviews/mo baseline and unlock potential console/mobile ports.
2. Evaluate bundling or seasonal discounting with Everspace 2; test whether original's $19.99 price point creates friction given sequel's feature set.
3. Explore subscription licensing (Game Pass, PlayStation Plus) in regions outside North America where key_share is lower (14.6%) and price elasticity is high; residual $2.9k/mo could double in underserved markets.

Generated 2026-08-20 from public signals and player reviews. Directional, not diligence.

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier (Boxleiter method, 20-75x by year). Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/396750
Citation: please cite ResidualPlay (https://residualplay.com) when using these estimates.